{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:24:54Z","timestamp":1790328294246,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.bbrc.2003.11.094","type":"journal-article","created":{"date-parts":[[2003,12,4]],"date-time":"2003-12-04T06:59:03Z","timestamp":1070521143000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Anti-HIV-1 activity and mode of action of mirror image oligodeoxynucleotide analogue of zintevir"],"prefix":"10.1016","volume":"313","author":[{"given":"Hidehito","family":"Urata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kumashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kawahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Otake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2003.11.094_BIB1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1126\/science.1604320","article-title":"Total chemical synthesis of a d-enzyme: the enantiomers of HIV-1 protease show demonstration of reciprocal chiral substrate specificity","volume":"256","author":"Milton","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2003.11.094_BIB2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1128\/AAC.35.7.1386","article-title":"Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2\u2032-deoxy-3\u2032-thiacytidine (BCH 189), a novel heterocyclic nucleoside analog","volume":"35","author":"Soudeyns","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/AAC.36.1.202","article-title":"The separated enantiomers of 2\u2032-deoxy-3\u2032-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro","volume":"36","author":"Coates","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/AAC.36.4.733","article-title":"(\u2212)-2\u2032-Deoxy-3\u2032-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro","volume":"36","author":"Coates","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.36.3.672","article-title":"Activities of the four optical isomers of 2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes","volume":"36","author":"Schinazi","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB6","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/AAC.36.8.1688","article-title":"Effects of (\u2212)-2\u2032-deoxy-3\u2032-thiacytidine (3TC) 5\u2032-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma","volume":"36","author":"Hart","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB7","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1093\/nar\/26.12.2886","article-title":"TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its l-enantiomer","volume":"26","author":"Garbesi","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nsb1197-881","article-title":"Specific recognition of HIV-1 TAR RNA by a d-Tat peptide","volume":"4","author":"Huq","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB9","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/AAC.39.11.2426","article-title":"T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1","volume":"39","author":"Ojwang","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/07391102.1997.10508967","article-title":"Potassium-induced loop conformational transition of a potent anti-HIV oligonucleotide","volume":"15","author":"Jing","year":"1997","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/mol.53.2.340","article-title":"Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR-177 (Zintevir)","volume":"53","author":"Est\u00e9","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB12","doi-asserted-by":"crossref","first-page":"8174","DOI":"10.1021\/ja00021a057","article-title":"Mirror-image DNA","volume":"113","author":"Urata","year":"1991","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB13","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/nar\/20.13.3325","article-title":"Synthesis and properties of mirror-image DNA","volume":"20","author":"Urata","year":"1992","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB14","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/jvi.62.6.2107-2114.1988","article-title":"Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope","volume":"62","author":"Matsushita","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0026-895X(25)09263-6","article-title":"Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents","volume":"42","author":"Yamamoto","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1042\/bj3370585","article-title":"l-ATP is recognized by some cellular and viral enzymes: does chance drive enzymic enantioselectivity?","volume":"337","author":"Verri","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/mol.51.1.132","article-title":"Lack of enantiospecificity of human 2\u2032-deoxycytidine kinase: relevance for the activation of \u03b2-l-deoxycytidine analogs as antineoplastic and antiviral agents","volume":"51","author":"Verri","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB18","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1021\/jm00100a029","article-title":"l-Thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth","volume":"35","author":"Spadari","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB19","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1006\/bbrc.1994.1552","article-title":"Chiral discrimination of enantiomeric 2\u2032-deoxythymidine 5\u2032-triphosphate by HIV-1 reverse transcriptase and eukaryotic DNA polymerases","volume":"200","author":"Yamaguchi","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB20","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1093\/nar\/23.15.2840","article-title":"Stereospecificity of human DNA polymerase \u03b1,\u03b2,\u03b3,\u03b4 and \u03b5, HIV-reverse transcriptase, HSV-1 DNA polymerase, calf thymus terminal transferase and Escherichia coli DNA polymerase I in recognizing d- and l-thymidine 5\u2032-triphosphate as substrate","volume":"23","author":"Focher","year":"1995","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0026-895X(25)08773-5","article-title":"Effects of nucleotide analogs on human immunodeficiency virus type 1 integrase","volume":"49","author":"Mazumder","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB22","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1016\/S0021-9258(18)47090-1","article-title":"Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding","volume":"269","author":"Brown","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB23","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1074\/jbc.271.10.5698","article-title":"Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide","volume":"271","author":"Bishop","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB24","first-page":"53","article-title":"The molecular targets for HIV inhibitors","volume":"8","author":"De Clercq","year":"2000","journal-title":"Int. Antiviral News"},{"key":"10.1016\/j.bbrc.2003.11.094_BIB25","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1073\/pnas.85.16.6132","article-title":"Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro","volume":"85","author":"Baba","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2003.11.094_BIB26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1126\/science.2452480","article-title":"Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells","volume":"240","author":"Mitsuya","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2003.11.094_BIB27","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1074\/jbc.270.4.1754","article-title":"Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads","volume":"270","author":"Rando","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2003.11.094_BIB28","doi-asserted-by":"crossref","first-page":"13762","DOI":"10.1021\/bi960541u","article-title":"Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures","volume":"35","author":"Mazumder","year":"1996","journal-title":"Biochemistry"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X03024690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X03024690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T10:10:26Z","timestamp":1757758226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X03024690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0006291X03024690"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2003.11.094","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-HIV-1 activity and mode of action of mirror image oligodeoxynucleotide analogue of zintevir","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2003.11.094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}